Lexaria Bioscience’s (LEXX) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Lexaria Bioscience (NASDAQ:LEXX – Free Report) in a research report report published on Monday,Benzinga reports. HC Wainwright currently has a $10.00 target price on the stock. HC Wainwright also issued estimates for Lexaria Bioscience’s Q1 2025 earnings at ($0.12) EPS, Q2 2025 earnings at ($0.11) EPS, […]
More Stories
Is Crew Girl Renewed for Season 2? Release Date, Cast, and Production Details
Are you also a fan of Canadian drama? Miku and Kyle’s duo is returning with Crew Girl Season 2. It...
The Four Seasons Season 3: Release Date, Cast, Episodes, and More
Looking for an upcoming American romantic-comedy drama series? Good news! The popular friendship-based series is coming back. The Four Seasons...
Take Charge of My Heart: Release Date, Trailer, Plot, and More
Are you also hunting for the next Korean romantic-comedy drama? Then your search ends here. Take Charge of My Heart...
Minerva Academy: Release Date, Plot, Cast, Trailer, and More
Netflix’s latest Italian drama Minerva Academy is currently streaming online on the popular streaming network Netflix. Its original title is...
8 Best Commercial Skylight Companies for US Projects (2026)
Getting commercial daylighting wrong is expensive in a way residential work rarely is. A leaking curb on a house is...
Is Sweet Magnolias Season 6 Renewed? Latest News and Review
Netflix’s romantic drama Sweet Magnolias has finally come to an end. In September 2026, Deadline officially announced that one of...